![](/img/cover-not-exists.png)
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
Bisogno, Gianni, Jenney, Meriel, Bergeron, Christophe, Melcón, Soledad Gallego, Ferrari, Andrea, Oberlin, Odile, Carli, Modesto, Stevens, Michael, Kelsey, Anna, Paoli, Angela De, Gaze, Mark N, MartellLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(18)30337-1
Date:
June, 2018
File:
PDF, 409 KB
english, 2018